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DGMQ’s Asia Field Program in Thailand
The Centers for Disease Control and Prevention (CDC) has collaborated with the Thailand Ministry of Public 
Health (MoPH) for over 30 years. This collaboration has led to new prevention and control strategies that 
have had significant global public health impacts, especially in the areas of HIV, influenza, tuberculosis, and 
emerging infectious diseases. 
As the newest member of this collaboration, the Immigrant, Refugee, and Migrant Health (IRMH) Branch, part 
of CDC’s Division of Global Migration and Quarantine (DGMQ), conducts surveillance activities, responds to 
disease outbreaks, strengthens international partnerships, and conducts local outreach and health education 
activities through its Asia Field Program. Two of its primary activities center on the Mae Sot Processing Center 
and the Mae La refugee camp, both located in Western Thailand bordering Burma.
Mae Sot Processing Center for U.S.-Bound Refugees 
Since 2004, more than 60,000 refugees from Burma have resettled 
from Thailand to the United States. For all such refugees coming to the 
United States, a medical examination is mandatory to identify, for the 
Department of State and the U.S. Citizenship and Immigration Service, 
applicants with inadmissible conditions. These include communicable 
diseases of public health concern (notably TB disease, which requires 
successful completion of treatment prior to resettlement), physical and 
mental disorders with associated harmful behaviors, and substance 
abuse and addiction. 
CDC’s Division of Global Migration and Quarantine (DGMQ) develops 
and implements the medical screening guidelines, called Technical 
Instructions, used to conduct the exams. For refugees living in five 
refugee camps along the Thai-Myanmar border (inlcuding Mae La), 
these exams are conducted by physicians from the International 
Organization for Migration (IOM) at the Mae Sot Processing Center 
about 3-6 months before departure. With guidance from DGMQ, IOM 
also conducts pre-departure screenings 1-3 weeks before departure 
and pre-embarkation checks (fit-to-fly checks) 1-3 days before 
departure. 
DGMQ Public Health Activities 
Managing Infectious Threats: DGMQ provides on-going guidance to IOM on how to manage infectious 
threats to the U.S.-bound population during processing at the center. In an outbreak setting, such instructions 
can encompass treatment, prophylaxis, isolation, and/or travel restrictions. 
Vaccination and Presumptive Treatment: DGMQ developed evidence-based recommendations for 
pre-departure vaccinations, which are not mandatory for resettlement, and presumptive treatment with 
albendazole and ivermectin. At least one-third of the world’s population is infected with intestinal parasites, 
making it one of the most common conditions detected in refugees newly arriving to the United States. A 
successful pilot program to provide presumptive treatment for strongyloides infection with ivermectin for 
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refugees originating from Asia helped DGMQ reached a cost-sharing agreement with the Department of 
State Bureau of Population, Refugees, and Migration. The International Organization of Medicine will be 
funded to provide presumptive treatment for every refugee population at high risk for strongyloides. DGMQ 
will lead efforts to expand ivermectin presumptive treatment for all U.S.-bound refugees.
DGMQ’s science and expertise in disease detection was a successful precursor in changing the overseas 
public health screening and treatment of parasitic infections for refugees. Presumptive treatment represents 
a cost-effective and low burden method of protecting and improving refugee health. 
Enhanced Medical Exam: DGMQ, in collaboration with IOM, is currently piloting and evaluating a 
voluntary testing and treatment program for certain medical conditions during the mandatory exam. These 
conditions include intestinal parasites, anemia, and chronic hepatitis B virus infection. Positive results do 
not affect resettlement because these are not inadmissible conditions. Rather, testing would benefit the 
refugee, which will in turn benefit the receiving community.
Mae La Refugee Camp
Established in 1984, Mae La Refugee Camp is one of 
nine refugee camps along the Thai-Myanmar border.  
The camp has the largest refugee population, close to 
45,000 Karen refugees in a four-square-kilometer area. 
The camp is administered by the Royal Thai Government 
while non-governmental organizations (NGOs) provide 
healthcare, water and sanitation, and other services. 
Première Urgence–Aide Médicale Internationale, the 
main healthcare NGO and an important partner for 
DGMQ, provides care, free-of-charge in a field hospital 
with a 158-bed inpatient unit and two outpatient clinics. 
DGMQ Public Health Activities 
Vaccination for Cholera Prevention: Mae La has experienced cholera outbreaks in four of the last eight 
years. To supplement ongoing water and sanitation improvements with immunization using a new and 
more affordable oral cholera vaccine, DGMQ forged a coalition among Thai Ministry of Public Health 
(MOPH), Première Urgence - Aide Médicale, and Bill and Melinda Gates Foundation to deliver and evaluate 
a campaign for all 45,000 refugees living in Mae La. This project will generate a “road map” for vaccine 
intervention in similar settings and contribute to the evidence base that will define the public health role of 
oral cholera vaccination. 
Investigation and Recommended Remediation for Lead Poisoning: When U.S. providers reported 
elevated blood lead levels in refugee children arriving from Thailand, DGMQ conducted a field investigation 
to identify the cause. Risk factors for elevated blood lead levels included hemoglobin <10 g/dL, exposure to 
car batteries, and taking traditional medicines. Healthcare NGOs conducted remediation accordingly, and 
the study prompted a wider investigation by Thai health authorities beyond the camp’s borders. 
Strengthening Surveillance and Outbreak Response: DGMQ, in collaboration with the World Health 
Organizaion and Thai MOPH, provides ongoing technical and training support for healthcare NGOs, leading 
to stronger public health systems and better coordination between the NGOs and Thai health authorities. 
Mae La Refugee Camp, home to 
45,000 Karen refugees.
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